Signal Advisors Wealth LLC Acquires 1,886 Shares of Chemed Co. (NYSE:CHE)

Signal Advisors Wealth LLC boosted its position in shares of Chemed Co. (NYSE:CHE - Free Report) by 60.7% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 4,995 shares of the company's stock after purchasing an additional 1,886 shares during the quarter. Signal Advisors Wealth LLC's holdings in Chemed were worth $2,647,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. EP Wealth Advisors LLC lifted its holdings in shares of Chemed by 1.9% during the 3rd quarter. EP Wealth Advisors LLC now owns 1,354 shares of the company's stock valued at $814,000 after purchasing an additional 25 shares in the last quarter. Ballentine Partners LLC lifted its stake in Chemed by 4.1% in the third quarter. Ballentine Partners LLC now owns 655 shares of the company's stock valued at $394,000 after buying an additional 26 shares in the last quarter. Creative Planning boosted its holdings in shares of Chemed by 2.8% in the second quarter. Creative Planning now owns 1,228 shares of the company's stock valued at $667,000 after buying an additional 34 shares during the period. First Heartland Consultants Inc. increased its position in shares of Chemed by 7.2% during the third quarter. First Heartland Consultants Inc. now owns 508 shares of the company's stock worth $305,000 after acquiring an additional 34 shares in the last quarter. Finally, First Trust Direct Indexing L.P. raised its holdings in shares of Chemed by 4.5% during the third quarter. First Trust Direct Indexing L.P. now owns 887 shares of the company's stock worth $533,000 after acquiring an additional 38 shares during the period. Institutional investors own 95.85% of the company's stock.

Analysts Set New Price Targets

A number of research firms have issued reports on CHE. StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a report on Saturday, November 30th. Royal Bank of Canada decreased their price objective on Chemed from $697.00 to $633.00 and set an "outperform" rating for the company in a report on Tuesday, November 5th.

Chemed Stock Up 0.7 %

CHE traded up $3.93 during trading hours on Tuesday, hitting $534.04. 87,005 shares of the company's stock were exchanged, compared to its average volume of 81,788. The stock has a market cap of $8.04 billion, a price-to-earnings ratio of 26.99, a PEG ratio of 2.32 and a beta of 0.47. Chemed Co. has a 1-year low of $512.12 and a 1-year high of $654.62. The stock's 50-day moving average is $545.44 and its two-hundred day moving average is $562.63.

Chemed (NYSE:CHE - Get Free Report) last issued its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 EPS for the quarter, missing the consensus estimate of $5.76 by ($0.12). Chemed had a net margin of 12.69% and a return on equity of 27.86%. The company had revenue of $606.18 million for the quarter, compared to analyst estimates of $612.22 million. During the same period last year, the company posted $5.32 earnings per share. The business's revenue for the quarter was up 7.4% on a year-over-year basis. On average, equities research analysts anticipate that Chemed Co. will post 21.43 EPS for the current year.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Monday, November 18th were paid a $0.50 dividend. The ex-dividend date of this dividend was Monday, November 18th. This represents a $2.00 annualized dividend and a yield of 0.37%. Chemed's dividend payout ratio (DPR) is currently 10.11%.

Insiders Place Their Bets

In related news, VP Brian C. Judkins purchased 145 shares of the firm's stock in a transaction that occurred on Monday, December 30th. The shares were acquired at an average price of $519.50 per share, for a total transaction of $75,327.50. Following the purchase, the vice president now owns 1,678 shares in the company, valued at approximately $871,721. This represents a 9.46 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the firm's stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $572.77, for a total transaction of $1,145,540.00. Following the sale, the chief executive officer now owns 101,735 shares of the company's stock, valued at $58,270,755.95. This trade represents a 1.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 3.32% of the company's stock.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.